Jake Galson

Critic
DISC Type : C

Vice President of Technology at Alchemab Therapeutics Ltd

Greater Cambridge Area, United Kingdom

Overview

Jake is the Vice President of Technology at Alchemab Therapeutics, where he leads the development of a pioneering discovery platform using AI to identify novel therapeutics. A University of Oxford PhD graduate, he previously led bioinformatics at Kymab Ltd, developing the IntelliSelect® antibody discovery platform, and is recognized as a pioneer in immune receptor repertoire sequencing.

Driven by personal experience, Jake co-founded Phylax Technologies with his brother to develop tools that support people with neurodegenerative diseases like Alzheimers. This venture aims to help prevent accidental online purchases, addressing a common challenge for those with cognitive decline and their families.

He was inspired to start Phylax after a person he knew with young-onset Alzheimers experienced difficulties with accidental online shopping.

Personality Overview

Critic

ROI Driven

Precise

They prefer to analyze logically and value objective facts over emotions.  They like to take decisions independently and do not seek others' support often. It is very likely that they will negotiate pricing or other important terms.

Topics They Care About

AI in Drug Discovery
Leads Alchemab's technology platform integrating AI and immune system analysis to find new antibody therapeutics and targets, a central theme of his career and public commentary.
Antibody Therapeutics
His work at Alchemab and Kymab focuses on discovering novel antibodies. He follows industry developments like open-source antibody-antigen prediction models and de novo antibody design.
Neurodegenerative Diseases
Co-founded Phylax Technologies to create technology that supports people living with conditions like Alzheimer's, inspired by a personal connection to the cause.

Media Appearances

Jake has no verified media appearances

Work History

7-2023
Vice President of Technology at Alchemab Therapeutics Ltd
2-2023
Co-Founder at Phylax Technologies Ltd
1-2021 - 7-2023
Head Of Technology at Alchemab Therapeutics Ltd
3-2020 - 1-2021
Director Of Technology at Alchemab Therapeutics Ltd
5-2019 - 3-2020
Group Leader, Bioinformatics at Kymab Ltd

Education

2012 - 2016
Doctor of Philosophy - PhD from University of Oxford
2008 - 2011
BA from University of Oxford

More Information

Social Presence :

Prographics :

Exp : 12 Location : Greater Cambridge Area, United Kingdom Job Level : Senior Designation : Vice President of Technology at Alchemab Therapeutics Ltd
URL has been copied!

Insights For Selling To Jake

During A Call Or A Meeting

DO's

  • Be ready to answer many clarity-seeking questions and requests for information
  • Don’t forget to mention how you compare to competition on both features and pricing
  • If you can, show them industry reports or analyst comments instead of sharing anecdotal stories

DONT's

  • Avoid pushing them too much to involve other stakeholders unless it is critical
  • Don’t try too hard to build a relationship with them
  • Don't give superficial answers, they are easily rattled by them

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Jake is

  • Proof of ROI, low pricing and objective proof points are the important factors for them.
  • Will you ever get a clear answer from Jake

  • They do not mind saying no if they believe that it is the right decision.

Insights For Deal Planning

    How fast (or slow) will Jake move?

  • Their decision-making is neither very fast nor very slow, they are somewhere in between.
  • Can Jake take some risk or not?

  • They can take risks if their analysis shows that it would be worth it.

You And Jake

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.